Cardiovascular Disease (CVD): Clinical Trials

22 trials for Cardiovascular Disease (CVD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 6 recruiting, 2 unknown, 1 active not recruiting. 8 Not applicable, 3 Phase 2, 1 Early Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 6, Enrolling by invitation 1, Not yet recruiting 1
Phase 23Completed 3
Early Phase 11Completed 1
Phase 31Recruiting 1
Phase 41Completed 1

Follow Cardiovascular Disease (CVD): new trials by email Literature Review of Cardiovascular Disease (CVD) trials Research Report on Cardiovascular Disease (CVD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sacha Inchi-CoQ10 Supplementation and Cardiovascular Health
Sacha-Q10 Plus, Placebo - Cardiovascular Disease (CVD), Elevated Cardiovascular Risk
Not applicableNot yet recruitingHospital Pengajar Universiti Putra Malaysia602026-10-012026-08-28
REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension
observational study - Hypertension, Aldosterone Disorder
RecruitingKaiser Permanente5002026-08-202026-10-05
A Retrospective Real-World Cohort Study
No treatment given - Obesity, Type 2 Diabetes (T2D)
Active not recruitingNovo Nordisk A/S1000002026-08-202026-09-30
Cardiovascular Risk Assessment and Coronary Calcium Score in Thai MASLD Patients
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Cardiovascular Disease (CVD)
RecruitingWatcharasak Chotiyaputta2512026-06-242026-10-08
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
Tadalafil, Ambrisentan, Placebo (Ambrisentan-matching) - Pulmonary Arterial Hypertension (PAH), Comorbidities
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris1862026-04-282026-05-13
Study of the Progression of Chronic Cardiovascular Conditions
Cardiovascular Disease (CVD), Heart Failure
RecruitingProlaio50002025-10-302026-08-12
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
Feminizing GAHT, Masculinizing GAHT - Gender Incongruence, Cardiovascular (CV) Risk
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna5002025-07-182025-09-23
The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD.
Encourage using pedometer - Daily Step Count, MASLD
Not applicableEnrolling by invitationMahidol University862024-08-012025-05-15
Towards Personalized Nutrition With SCAPIS2-HOME
Dietary intervention - Cardiovascular Disease (CVD), Chronic Obstructive Pulmonary Disease (COPD)
Not applicableCompletedChalmers University of Technology16412024-01-012026-03-19
A Genomic Approach for Clopidogrel in Caribbean Hispanics
CYP2C19 test, P2RY12 assay - Cardiovascular Disease (CVD), Stroke
Early Phase 1CompletedUniversity of Puerto Rico1502020-09-012026-06-02
Women's Advanced Risk-assessment in Manitoba
Cardiovascular Disease (CVD), Cardiovascular Risk Factor
RecruitingSt. Boniface Hospital10002019-10-012021-01-28
Optimised Lung Cancer Screening to Prevent Cardiovascular and Pulmonary Diseases Coupled With Primary Prevention
Lung Cancer, Cardiovascular Disease (CVD)
UnknownIstituto Clinico Humanitas20002018-10-102020-03-20
Veteran Peer Coaches Optimizing and Advancing Cardiac Health
Community-based peer health coach intervention - Cardiovascular Disease (CVD), Hypertension
Not applicableCompletedVA Office of Research and Development2642017-05-302024-08-09
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
17beta Estradiol, Transdermal placebo patch, Progesterone - Estrogen Deficiency, Cardiovascular Disease (CVD)
Phase 2CompletedCedars-Sinai Medical Center292017-01-012025-03-13
Carolina Heart Alliance Networking for Greater Equity
CHANGE Study - Cardiovascular Disease (CVD)
Not applicableCompletedUniversity of North Carolina, Chapel Hill3862016-09-112019-10-08
The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
Rosuvastatin - Human Immunodeficiency Virus (HIV), Cardiovascular Disease (CVD)
Phase 4CompletedOttawa Heart Institute Research Corporation352014-09-012018-10-05
The Effect of Pomegranate Juice (PJ) on Oxidative Stress Biomarkers During Treatment With IV Iron During One Dialysis Session
PJ, IV iron - Cardiovascular Disease (CVD)
Not applicableCompletedWestern Galilee Hospital-Nahariya252014-04-012016-02-09
A Randomized Trial of Patient Financial Incentives to Reduce CVD Risk
Behavioral Economics Intervention - Cardiovascular Disease (CVD)
Not applicableCompletedUniversity of Pennsylvania532014-01-012014-12-10
Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)
Pentoxifylline, Placebo, Standard Treatment - Major Depressive Disorder, Depression
Phase 2CompletedIndiana University362012-06-012015-12-03
Beating the Blues for Your Heart
Beating the Blues (BtB), Usual Care - Depression, Depressive Symptoms
Phase 2CompletedIndiana University292011-07-012022-12-29

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Cardiovascular Diseases (22)  ·  Coronary Artery Disease (3)  ·  Hypertension (3)  ·  Depression (2)  ·  Heart Diseases (2)  ·  Heart Failure (2)  ·  Inflammation (2)  ·  Motor Activity (2)  ·  Obesity (2)  ·  Peripheral Arterial Disease (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Acute Coronary Syndrome (1)  ·  Alcohol Drinking (1)  ·  Amenorrhea (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (10)  ·  Pathologic Processes (9)  ·  Vascular Diseases (7)  ·  Arterial Occlusive Diseases (4)  ·  Arteriosclerosis (4)  ·  Behavior (4)  ·  Myocardial Ischemia (4)  ·  Chronic Disease (3)  ·  Coronary Disease (3)  ·  Disease Attributes (3)  ·  Heart Diseases (3)  ·  Lung Diseases (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Respiratory Tract Diseases (3)

Interventions

Diet Therapy (1)  ·  Estradiol (1)  ·  Observation (1)  ·  Pentoxifylline (1)  ·  Progesterone (1)  ·  Rosuvastatin Calcium (1)  ·  Tadalafil (1)  ·  Therapeutics (1)  ·  ambrisentan (1)  ·  ferryl iron (1)

Sponsors

Indiana University (2)  ·  University of Pennsylvania (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Cedars-Sinai Medical Center (1)  ·  Chalmers University of Technology (1)  ·  Hospital Pengajar Universiti Putra Malaysia (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)  ·  Istituto Clinico Humanitas (1)  ·  Kaiser Permanente (1)  ·  Mahidol University (1)  ·  Novo Nordisk A/S (1)  ·  Ottawa Heart Institute Research Corporation (1)  ·  Prolaio (1)  ·  St. Boniface Hospital (1)  ·  University College, London (1)

Countries

United States (9)  ·  Canada (2)  ·  Italy (2)  ·  Thailand (2)  ·  Denmark (1)  ·  France (1)  ·  Israel (1)  ·  Puerto Rico (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Batya Kristal, MD (1)  ·  Chanita H Halbert, PhD (1)  ·  Chrisandra Shufelt, MD (1)  ·  Gary Small, MD MRCP (1)  ·  Girish Dwivedi, MD MRCP PhD (1)  ·  Harry Hemingway, FRCP (1)  ·  Jesse C Stewart, PhD (1)  ·  Jesse C. Stewart, Ph.D. (1)  ·  Jorge Duconge, PhD (1)  ·  Karin M. Nelson, MD MSHS (1)  ·  Noel Bairey-Merz, MD (1)  ·  Phunchai Charatcharoenwitthaya, MD (1)  ·  Samuel Cykert, MD (1)

Results publications

PMID 12941756, PMID 17327354, PMID 18820647, PMID 18972405, PMID 19444870, PMID 19875730, PMID 20533774, PMID 21206486, PMID 21330592, PMID 21618575, PMID 22958053, PMID 25040896, PMID 25145475, PMID 25580206, PMID 26378644, PMID 26610348, PMID 26707365, PMID 27038645, PMID 27836992, PMID 27917585, PMID 27936024, PMID 28039099, PMID 28331015, PMID 28335038, PMID 28545937, PMID 28585193, PMID 28879026, PMID 29042429, PMID 29296097, PMID 29610219, PMID 29984130, PMID 30172037, PMID 31949537, PMID 32085707, PMID 32207804, PMID 32522147, PMID 32683103, PMID 32882428, PMID 32967678, PMID 33259835, PMID 33898961, PMID 34035097, PMID 34166721, PMID 34415683, PMID 35422132, PMID 36719059, PMID 36727674, PMID 37278999, PMID 37610989, PMID 37676198

NIH funding

2023 (1), R24MH080827 (1), U48DP005017 (1), U54MD007600 (1)